chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe rash all over arms, stomach, back, sides, neck; no prescription cream worked, neither did a steroid.  Lasted 3 months
I previously reported swollen lymph nodes in my left arm but since the , April 9 I began spotting for 3.5/4 days. The discharge was pink/red and jelly like. Was not free flowing or strong enough to fill a pad. I took two pregnancy tests and both were negative.   Menstrual cycle: 03/28/21-04/01/21 Vaccine dose 2: 04/03/21 Spotting/bleeding: 04/09/21-04/12/21 Negative pregnancy tests: 04/12/21 & 04/15/21 *Predicted period: 04/26/21
COMPLICATIONS AFTER THE VACCINE; This spontaneous report received from a consumer via a company representative concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced complications after the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of complications after the vaccine was not reported. This report was non-serious.
Started a rash but it has occasional bumps on my skin, feels like it's under my skin sometimes. It looks like a red mark slightly raised and itchy. It's extremely discomforting and keeps me awake at night because it itches so badly. I went to the doctor in the end of November and immediately showed her the problem, she gave me an anti-itch ointment Triaminicin. I'm going to see her again in three weeks to complain again. Not sure if it is related to the vaccine.
This spontaneous report was received from a physician referring to a female patient of unknown age. No information was provided regarding the patient's medical history. Concurrent conditions included anxiety, for which she was being treated with an unspecified anxiety medication. On 20-JUN-2017, the patient was vaccinated with the second dose of GARDASIL 9 intramsucularly, for prophylaxis (dose, lot number and expiration date were not provided). On the same date, the patient experienced dizziness. The patient sought medical attention and the physician had the patient lay down. The patient recovered from the event on 20-JUN-2017. The reporter did not provide a causal relationship between the event dizziness and therapy with GARDASIL 9. No product quality complaint was filed.
Profuse menstrual bleeding- large clots for 2 days. Pain behind eyes morning after injection. Painful lymph nodes on underarms.
Narrative :  Symptoms: SkinRash& SWOLLEM GLANDS UNDER JAW-SORE.  BLISTERS DEVELOPED WHERE THE RASH WAS ON PTS KNEE  Treatment:
Pt recv vax on 3/1/99; 2 hr post vax pt exp flushed w/ fever (102),thirst, headache, chills, light headed, vision difficulty, rt arm red; tx=Advil, adult strength Tylenol
In one hour, extremely dry month, tongue and throat. Sharp pain on left side of forehead that would come and go. Overall, not feeling well.  A few  hours later (about 4 hours), tingling and numbness (neuropathy) in my lower legs and arms. Some neuropathy on left side of face.
Within 5 to 15 minutes of getting the vaccine, my right ear stopped up and feels like it need to pop, and I have some hearing loss in my right ear.
Within 5 minutes after receiving 2nd Pfizer vaccine, patient started to become sweaty and light headed. Patient did not faint, but became unresponsive and mother had to help him sit in a chair. Gave patient water and took his temperature, since he was feeling warm/sweaty. Temperature was normal at 97.6. Inspected injection site and didn't notice anything abnormal. After about 30 seconds to 1 minute, patient became responsive again, was speaking like normal, and drinking water. Patient has cerebral palsy and mother states he has seizure-like activity where he becomes unresponsive due to his condition. Used to have physical seizures and was on medication previously, but hasn't had one in a long time so no longer taking seizure medication. Mom said these seizure-like episodes cannot be treated with medication, so they just help him through when they happen periodically. Patient did not have a reaction to first Pfizer vaccine, so mother and I think being nervous/excited triggered this episode and that it was unrelated to the actual vaccine. Patient and mother sat in pharmacy area for about 30 minutes before leaving.
Client diagnosed with COVID Jan 2021 Vaccinated with Jannsen 4/3/2021 Lost his mother May 2021 Diagnosed with bipolar depression and schizophenia June 2021 Separated from wife of 42 years September 2021 72 hour hold at a psychiatric facility in November 2021 Suicide by hanging November 2021 - wife believes he sustained organic changes to the brain after the COVID infection in January that ultimately resulted in his demise.
Slight body aches the day after, getting more prominent by 3:00 and worse in the evening. Pain was both widespread and often sharp. Bad continual leg pain late evening and bedtime. Was able to fall asleep without too much trouble and pain was gone by morning. Did not take Advil or other pain relief medication.
Immediate excruciating pain at time of injection. Within a matter of hours, shoulder was stiff, with sharp pain and reduced mobility. Symptoms have proceeded to worsen with time (over the last 5.5 weeks). No previous issues or injuries to the shoulder.
pt had physical & 2 mo immun on 18APR; pt died on 19APR94-was sleeping on mattress between parents on back w/pillow under head;
she got the booster dose, 10 months after her second shot; Arm tingling; fingers are numb; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 35 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose, She got the first shot and had no problems), for COVID-19 Immunization; Bnt162b2 (Second Dose), for COVID-19 immunization, reaction(s): "little pain in her arm".  The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "she got the booster dose, 10 months after her second shot"; PARAESTHESIA (non-serious), outcome "unknown", described as "Arm tingling"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "fingers are numb".  Additional Information: Consumer (Parent) reported that his daughter (patient) got the first shot and had no problems. The second shot she had a little pain in her arm. On Friday she got the booster dose, 10 months after her second shot. Since Friday her arm has been tingling and her fingers are numb. She called her doctor, but her doctor is not sure what is going on.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101796270 Same patient and drug, different event separated in time
This spontaneous report was received from a medical assistant and refers to a unspecified patients of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions and allergies and concomitant therapies was reported. On an unknown dates, multiple doses of improperly stored M-M-R II lot # L026553 with expiration date 16-JUL-2017 and M035388 with expiration date 02-AUG-2018 were administered to multiple unspecified patients for prophylaxis. Improperly stored vaccines underwent following temperature excursion: 9 Celsius degrees to 25 Celsius degrees (8.5 Celsius degrees) for 12 hours. Data logger was involved. No adverse event was reported.; Sender's Comments: US-009507513-1708USA005614: US-009507513-1708USA005615: US-009507513-1708USA005616: US-009507513-1708USA005617:
PRESSURE AND SQUISHY FEELING IN THE HEAD, TINGLING, WEAKNESS AND STIFFNESS IN EXTREMITIES, ELEVATED FEELING LIKE GOING UP AN ELEVATOR, ANXIETY.
Initial information received on 25-Sep-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case is linked with 2018SA267442 and 2018SA271680. This case involves a female patient (unknown age) who was exposed to a vaccine FLUZONE HIGH DOSE on an unspecified age (lot number, exp date, dosing details, route and site of administration not reported). It was a case of vaccine exposure during pregnancy. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The date of last menstrual period was not reported. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It is a pregnancy case reported that the patient had FLUZONE HD inadvertently given to 3 pregnant patients, increase rate of injection site reaction (no study in pregnancy) and FLUZONE HD inadvertently given to several pregnant patients occurred at unknown gestation period. It was not reported if any adverse event occurred (reported as no knowledge or information about the event whatsoever). Pregnancy outcome was not reported. List of documents held by sender: none.
PAIN & SWELLING & RASH at the injection site which eventually involved the entire arm. Lymph nodes swollen and tender into armpit and involved neck and left jaw (like when I had the mumps as a child). FEVER: 102.6* lasting two days,( took Tylenol 500mg to reduce swelling and lower temp)  FEVER continued above 100* for 14 days and has remained to present HEADACHE (severe) NAUSEA (some vomiting-mostly bile) Dizziness/loss of balance Body-wide aches and pain Weakness and fatigue Loss of hair (significant and fast) Digestive problems/loss of appetite/extreme nausea WEIGHT LOSS
Visualize geometric figures while on computer; Couldn't get out of bed cause was stiff; Pain in every joint; This spontaneous case from was received on 12-Oct-2023 from other non-healthcare professional via  Communications (reference number SEQW23-03327) and concerned a patient of unreported age and gender.  The patient's medical history and concomitant medications were not reported.   On 04-Oct-2023, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose: 0.5 ml; route of administration, anatomical location: not reported) as the doctor prescribed, as reported. The batch was not reported.  On 05-Oct-2023, one day after receiving Fluad Quadrivalent vaccine, the patient could not get out of bed because he was stiff and had felt pain in every joint.  On 06-Oct-2023, the patient visualized geometric figures while on the computer.  On 09-Oct-2023, the patient went to the ophthalmologist, and he said that it was not from the eyes and that there was nothing wrong with the retina.  At the time of initial reporting, the patient was recovering from the events of 'visual impairment', 'musculoskeletal stiffness', and 'arthralgia'. It was reported that the patient got better from the symptoms.  The reporter did not provide a causality assessment.  This case was assessed as non-serious.  Company comment: A patient was vaccinated with Fluad Quadrivalent. One day after vaccination, the patient experienced stiffness and felt pain in every joint. As reported, the patient visualized geometric figures while on the computer. The patient went to the ophthalmologist, and he said that it was not from the eyes and that there was nothing wrong with the retina. The patient's medical history and concomitant medications were not reported. Information regarding additional laboratory findings and diagnostic data was not provided. Causal role of the suspect vaccine cannot be excluded and is assessed as possibly related for the event musculoskeletal stiffness, arthralgia and visual impairment, with the currently available information and chronological plausibility.; Sender's Comments: A patient was vaccinated with Fluad Quadrivalent. One day after vaccination, the patient experienced stiffness and felt pain in every joint. As reported, the patient visualized geometric figures while on the computer. The patient went to the ophthalmologist, and he said that it was not from the eyes and that there was nothing wrong with the retina. The patient's medical history and concomitant medications were not reported. Information regarding additional laboratory findings and diagnostic data was not provided. Causal role of the suspect vaccine cannot be excluded and is assessed as possibly related for the event musculoskeletal stiffness, arthralgia and visual impairment, with the currently available information and chronological plausibility.
17AUG95 devel swelling, pain, erythema lt arm below site; admitted to fever @ home one noc; rechecked 22AUG-23AUG-25AUG-29AUG; warm compresses & Advil prescribed; 29AUG95 erythema & most of swelling resolved
COVID+ 11/4/22 - Vaccination status - moderna x4 Discharge Physician: MD,  Primary Care Physician: DO  Date of Admission: 11/4/2022 Discharge Date: 11/10/2022 Room Number:    BRIEF OVERVIEW:   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 11/04/2022 Yes ? Pneumonia LUL 11/04/2022 Yes ? Toxic metabolic encephalopathy 11/04/2022 Yes ? PAD (peripheral artery disease) (HCC) 05/20/2022 Yes ? Chronic obstructive pulmonary disease with acute exacerbation (HCC) 05/14/2021 Yes ? Paroxysmal atrial fibrillation  with RVR 05/14/2021 Yes ? Essential hypertension    DETAILS OF HOSPITAL STAY:   PRESENTING PROBLEM: COPD exacerbation (HCC) [J44.1] Pneumonia of left lung due to infectious organism, unspecified part of lung [J18.9]   HOSPITAL COURSE: 82 y.o. caucasian male patient with past medical history chronic obstructive pulmonary disease, dementia, dysphagia, paroxysmal atrial fibrillation, hypertension, PAD. presents from his care facility via EMS with increased dyspnea, severe wheezing, shortness of breath   Laboratory data reviewed showing WBC 12K initial lactate normal via point of care in ER, patient's heart rate 110's to 130s, without significant tachypnea but noted some lethargy and ineffective cough with upper airway wheezing.  He received duo nebulized bronchodilators as well as 125 mg IV Solu-Medrol in the ER.  CT angiogram thorax obtained for further evaluation to rule out PE.  Noted negative for pulmonary embolism, left upper lobe pneumonia, small left pleural effusion, bronchial thickening and mucous plugging which may be indicative bronchitis. Patient tested positive for COVID-19, patient was noted to be in acute respiratory distress, acute hypoxic hypercapnic respiratory failure secondary to viral pneumonia.  Patient was treated with IV dexamethasone and started on IV remdesivir completed 5 day course.  Patient was gradually weaned off oxygen transition to hear.  Patient was initially started on Rocephin and azithromycin however after a procalcitonin was negative antibiotic was discontinued. Patient was noted to have E coli urinary tract infection for which he was treated with IV Rocephin and transition to oral Ceftin and completed course of antibiotic during the hospitalization. Patient does have history of dementia with progressive deterioration of his mentation.  Home medications were continued acute encephalopathy was noted at the time of admission which progressively improved and patient was back to baseline. He was also noted to have dysphagia for which speech therapy was consulted and video fluoroscopic study was completed speech adjusted as dysphagia diet PT/OT recommended return to SNF. MSW/CM consulted for discharge planning. Patient able to return to mission point which was arranged. Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge. CONSULTANTS: SLP PT/OT MSW/CM INPATIENT PROCEDURES: VFSS
Patient described pain in his  upper arm and that is arm felt heavy shortly after receiving his first dose of the pfizer covid 19 vaccine being used under an emergency use authorization
Administration error - 17 year old was administered a dose of Moderna at our vaccination site.  The 17 year old's mother consulted with a physician and was able to book an appointment, despite not being on our pre-registration list from The Health Department. We are implementing an age screening process for people not on the pre-registration list so that this does not happen again in the future. I informed the 17 year old's mother of this administration error. She said her daughter did not have an adverse reaction to yesterday's shot and is high risk due to a health condition, which is why they proceeded with the appointment at the recommendation of their physician.
From initial information received on 11/26/2002, it was reported that a 4 month old male infant received a second dose of ACTHIB, Lot # UA666AA, intra-muscularly in the right thigh, a second dose of IPOL, Lot # 1645-2, intra-muscularly in the left thigh and second dose of TRIPEDIA, Lot # U0582AA, intra-muscularly in the right thigh at 11:30 AM on 11/12/2002.  The patient experienced redness, puffiness, inconsolable crying and was fussy, at 12:00 PM on the same day as vaccination.  Patient recovered from these reactions.  It was reported that the patient had experienced an unspecified adverse event on 09/11/2002 at the age of 2 months following a second dose of Hepatitis B vaccine.  The case is closed.  Linked to cases: U2002-01099, U2002-01114, U2002-01117 & U2002-01138.
Patient is fully vaccination.  COVID positive on 5/3/2022.  ED visit on 5/4/2022. 17y.o. female presenting to the emergency department for chest pain. Patient states she had symptoms of headache which is now mild, nausea, abdominal pain, cough, fever, however fever has resolved. Denies history of PE or DVT, cancer, surgery or trauma in the previous 4 weeks, or prolonged immobilization. Denies hemoptysis, hormone use, leg pain or leg swelling. CXR: No acute cardiothoracic process. No EKG done. Medications: toradol, tylenol, zofran, pepcid.  Discharged home.
about 12 hours out had severe body aches, shaking chills, headache and temp of 100.  those symptoms resolved 48 hours post injection but had upset stomach and loose stool which persisted. 1st injection just had soreness at site and a mild headache
Adverse Events: Dizzyness, fever, GI upset, shortness of breath and weakness. Treatment: Tylanol and rest Outcome: Not much improvement.
THE IMMUNIZATION WAS DRAWN UP INCORRECTLY. THE 2 VIALS WERE NEVER MIXED TOGETHER SO HE DID NOT RECEIVE THE POWDER PORTION
Induration and erythema, largest size 2 3/4 inches x 4 inches. Hot and hard tender to touch. Started increasing in size at about 24 hours post injection and stopped at about 40 hours post injection. At 4 days post remains 2 3/4 x 4 in. indurated, hard and painful.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2022 at 1:55 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 11-Mar-2022 at 1:55 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 11-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-542869 (Patient Link).
mom is positive for varicella; had been breastfeeding until the infant developed the rash; This spontaneous report was received from a physician and refers to a 41-old female patient. The patient's concurrect conditions, medical history, concomitant medications, drugs reactions or allergies were not provided.  On 12-DEC-2020, the patient was vaccinated post partum with varicella virus vaccine live (oka/merck)(VARIVAX)in left upper right arm ( lot # 279202867, dose and expiration date were not reported)  since it was determined, that she was seronegative for varicella virus vaccine (VZV) (for prophylaxis). The physician reported that the patient was not sure if she had chicken pox in the past and there were no available medical records for her. The physician also stated that there was no known recent exposure to VZV and confirmed that the patient did not develop an injection site reaction or rash post-vaccination. An immnunological work-up was not performed for the patient. It was reported that on 12-JAN-2021, the patient's child developed diffuse distribution of vesicles. The physician reported that the baby's rash specimen was collected on 14-JAN-2021, which was approximately 8 hours after acyclovir treatment began. The polymerase chain reaction (PCR) sample was tested on 15-JAN-2021 and revealed the vaccine strain (it was also reported that the infant developed chickenpox 30 days post maternal vaccination). The physician reported that patient was breastfeeding until the infant developed the rash (maternal exposure during breast feeding ). The infant had more that 20 diffuse lesions on her trunk, legs, arms, face It was reported that the baby was treated with acyclovir for a total of seven days and reported that the baby was currently "doing well." The physician also stated that an immunological work-up for the baby was performed and the results were pending. The outcome of varicella virus test positive was not reported.  The causal relationship between varicella virus test positive and varicella virus vaccine live (oka/merck)(VARIVAX ) was not provided.  This is one of the two linked reports of mother and child (the child case # 2101USA008744).; Sender's Comments:  US-009507513-2101USA008744:
Within 30 min was acting "odd". Head felt "buzzed", "foggy". Difficulty concentrating. Unable to do certain activities. After several hours foggy feeling left then was "antsy", couldn't sit still. Fell asleep - awoke fine.